Research Article: MAGEDB is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
Abstract:
Gastric cancer (GC) is the fifth most common cancer and the second leading cause of cancer death in the world. It is a complex disease caused by the interaction of the environment and related factors of the host. The main reasons for its high mortality include its silent nature, terminal clinical manifestations, and potential biological and genetic heterogeneity.– Stomach adenocarcinoma (STAD) is a typical example of heterogeneous malignant diseases, which has different subtypes and clinical behaviors, and is affected by a variety of genetic and environmental factors. The accurate diagnosis and individualized treatment of STAD are serious challenges in modern medicine. The factor closely related to the prognosis of STAD is the tumor staging., In addition, the tumor location, tumor size, histological type, grading, depth of tumor invasion, regional lymph node involvement, distal metastasis and other factors are also reported to be related to the prognosis of STAD.– In the last years, the genetic changes of many genes have been found in gastric cancer. These genes play an important role in many cellular functions, such as signal transduction, proliferation and invasion.
Introduction:
Gastric cancer (GC) is the fifth most common cancer and the second leading cause of cancer death in the world. It is a complex disease caused by the interaction of the environment and related factors of the host. The main reasons for its high mortality include its silent nature, terminal clinical manifestations, and potential biological and genetic heterogeneity. – Stomach adenocarcinoma (STAD) is a typical example of heterogeneous malignant diseases, which has different subtypes and clinical behaviors, and is…
Read more